Nabumetone News
Arthritis Drug Settlement
We have a Your Stories Q&A about the arthritis drug Relafen, and its generic counterpart Nabumetone. Some of you who take those medicines are getting $70 checks in the mail, and you're wondering why, and if the money is...
Some NSAIDS Safe in Ulcerative Colitis or Crohn's
Rochester, Minn., - Patients with inflammatory bowel disease can use once-forbidden non-steroidal anti-inflammatory drugs (NSAIDS) safely, at least in certain circumstances, according to two studies.
BPC 2005 Prize winners
Two PhD students, working within the Pharmaceutical Science Research Division were awarded prizes at this year's British Pharmaceutical Conference 2005.
Bad News for Cox-2 Inhibitors Was Good News for Mobic
Washington -The departure of Vioxx (rofecoxib) from pharmacists' shelves last September triggered a boomlet for Mobic (meloxicam), which then boosted its price by 9%, according to a Consumers Union analysis.
Eon Labs - Generic News - initial public stock offering - Brief Article - Statistical Data Included
Generic drug maker Eon Labs priced its initial public stock offering of 9.8 million shares at $15 on its first trading day, May 23.